Ryan Mee, CEO of Fulcrum Metals, reviews FY23 and progress on the Gold Tailings Hub in Canada. Watch the video here.
Agree Soleboy thanks for info.
Avacta board has permanent troll squatters
I don’t have to name them we all know who they are paid disrupters which need to move on.
I use to enjoy popping on the board looking for good research but it’s tiresome now.
Can’t wait for re- rate news to get back in the black and burn the rats.
I’d like to see CC mix it up with RNS news, 2WD cohorts results, director changes price sensitive news release ASAP midday RNS’s.
It’s too easy for City and traders to play with Avacta and Trolls just sit here all day every day disrupting.
Throw some news out at unexpected times don’t let them settle into patterns.
Panic the shorters to move on to other shares…
This is why AVA6000 market share will dramatically increase.
Over 65’s there is no chemo for STS
Dox not given to elderly.
There are no data regarding the management of advanced soft-tissue sarcoma (STS) in elderly patients.
Conclusion
A high proportion of elderly patients with advanced STS were denied chemotherapy. Further efforts are needed to define better the optimal care for fit and unfit elderly patients with STS.
https://www.sciencedirect.com/science/article/pii/S0923753419366438
I noticed in this weeks presentation CC spoke with a lot of excitement about timelines later this year.
I hope at long last LTH’s get a commercial deal either
T/O ,partnership or LD this year.
AS just kept kicking the can down the road,every inflection point promised never came to fruition.But he had a knack of releasing just an enough of a carrot to keep us all invested.
Plenty of cloak and daggers with AS ,which I hope CC changes and starts to communicate more with SH’s.
A few times SH’s let it be known they were not happy but AS was like a bully it’s my ball I can do what I want.
I remember one Interview SH’s demanded with Paul Hill his face was a picture he was fuming and you could tell from his body language he didn’t want to be there.
Now he has gone I’m hoping for a return on my investment from this company after 4 years of just pumping money in.
They have the Holy Grail now it’s time to tell the world.
GLA
When your CEO is an expert oncologist,and you hear the excitement and vision she has for the Pre/Cision Pipeline this is a no brainer.
CBO very busy multiple discussions with BP companies.
Oncologists, Patient Advocates and BP all discussing at AACR
Board strengthening coming sooner hopefully,
Count Dracula Gardiner gone soon and new CFO appointed
Expect an offer for DX very soon, I have a hunch it will be from AS.
His downfall was the DX side of the business and he is probably busy finding investors and an offer at the same price of Heights debt will offered soon so he can go back to his beloved affimers.
Last point will AS still be on the board of Affyxell.
Bella,Ice
If you want to make positive comments put them on a positive thread.
Your keeping a Troll thread at the top of the board
Trolls last few weeks AS hasn’t got a clue mistake after mistake false promises…
Trolls today but AS started company should of kept him…
FFS it’s a company that’s needs Top guidance at this stage in its history.
Bye Oxygen can you take Wynbag with you
Not just PI’s complaining some major II investors know what they have got and know they need a team to extract the best possible outcome from BP.
I expect at least one more to move on.
Now let’s get serious ….. Roll on Avacta
Https://avacta.com/christina-coughlin-md-phd-appointed-chief-executive-officer-of-avacta-group/
Avacta announces that Christina Coughlin, MD, PhD, has been appointed as the new Chief Executive Officer of Avacta. avacta.com/christina-coug… #AVCT
Great post Soleboy
Start of Pre/Cision trial
Smith, Bell ,McClaughlin.
Didn’t see any mistakes through trial everything went well,but it’s now
Smith, Coughlin,Bennett
All this change at the top will affect SP and damage the company?
SP held up when Bell ,McClaughlin were dropped in one liners in RNS’s
Only damage has been car crash placing last few months.
Out the 5 of them only Smith keeps over promising.
Gardiner sitting in the background giving himself shares.
Let’s see what happens next week.
I’m hoping side ways move for Smith and Gardiner moved to Man City accounting team were he would fit in.
Gardiner shocking
With his skills on the abacus,
Man City would be a good career move.
Vote him out, No wonder we are in this mess.
Another way to move to a quicker FDA approval.
I wonder if Avacta have signed up.
AVA6000 meets all the criteria:
Purpose of the RTOR
The Oncology Center of Excellence Real-Time Oncology Review (RTOR) aims to provide a more efficient review process to ensure that safe and effective treatments are available to patients as early as possible, while improving review quality and engaging in early iterative communication with the applicant.
RTOR facilitates earlier submission of topline efficacy and safety results, prior to the submission of the complete application, to support an earlier start to the FDA’s evaluation of the application.
Submissions to be considered for the RTOR program should meet the following criteria:
* Drugs likely to demonstrate substantial improvements over available therapy or meeting criteria for Expedited Programs.
* Straightforward study designs.
* Endpoints that can be easily interpreted (e.g., overall survival, response rates, etc.).
FDA will also consider whether adequate dose optimization has been performed to support the proposed dosage. Submissions with greater complexity will be considered for RTOR on a case by case basis. Additionally, FDA prefers the Assessment Aid (AAid)be used with RTOR.
https://www.fda.gov/about-fda/oncology-center-excellence/real-time-oncology-review
Avacta with has a £160m MCap now,
BOD halved the value of the company to receive just £31m.
Doesn’t want to do small deals to protect IP in case they receive BP deal.
Has done multiple deals in the past for just a few million upfront payments.
Doesn’t make any sense….
Can’t wait for Monday with the 40 day blackout lifted on Friday after trading.
18th March to 26th April.
Why the blackout ?
Fund has invested NASDAQ rules.
Could it be one of these funds who all invest in ground breaking science.
Let’s hope for an after hours RNS Friday….
Takeda Ventures Inc
https://www.takeda.com/science/research-and-development/partnerships/tdv/
Pfizer Ventures Inc
https://www.pfizer.com/about/partners/venture-investments
Novartis Venture Fund
https://www.nvfund.com/
GLA..
Can I order these for Gardiner.
https://www.bouncykings.co.uk/category/side-stall-and-garden-games/702/wooden-stocks
PL are yours better than these…
https://www.ebay.co.uk/b/bn_75394466
Over subscribed by II’s and oversubscribed by PI’s,Raising 31 million.
Why didn’t they just ask the market for £70 million explain its to pay off Heights and cash for trials.
Although more diluted but with heights gone and AACR data release,SP and Avacta would be in a very strong position now.